Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding BBC?
Track your performance easily
BBC Price & Analysis
BBC ETF Chart & Stats
Day’s Range― - ―
52-Week Range$22.66 - $31.99
Previous Close$24.23
VolumeN/A
Average Volume (3M)2.37K
AUM9.56M
NAV24.19
Expense Ratio0.79%
Holdings Count125
Beta1.70
Inception DateDec 16, 2014
Last Dividend Ex-Date
Dec 20, 2023Dividend Yield
(―)Shares Outstanding400,004
Standard Deviation0.10
10 Day Avg. Volume2,834
30 Day Avg. Volume2,365
Alpha-0.00979
Virtus LifeSci Biotech Clinical Trials ETF (BBC) Fund Flow Chart
Virtus LifeSci Biotech Clinical Trials ETF (BBC) 1 year Net Flows: -$1M
BBC ETF News
BBC ETF FAQ
What was BBC’s price range in the past 12 months?
BBC lowest ETF price was $22.66 and its highest was $31.99 in the past 12 months.
What is the AUM of BBC?
As of Dec 19, 2024 The AUM of BBC is 9.56M.
Is BBC overvalued?
According to Wall Street analysts BBC’s price is currently Undervalued.
Does BBC pay dividends?
BBC pays a Notavailable dividend of $0.082 which represents an annual dividend yield of N/A. See more information on BBC dividends here
How many shares outstanding does BBC have?
BBC has 400,004 shares outstanding.
Which hedge fund is a major shareholder of BBC?
Currently, no hedge funds are holding shares in BBC
BBC ETF Smart Score
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
U.S. Dollar
2.21%
Omeros Corporation
1.02%
Prothena Corporation
0.98%
Annexon Biosciences, Inc.
0.97%
Arcutis Biotherapeutics Inc
0.97%
Edgewise Therapeutics, Inc.
0.92%
Zymeworks
0.91%
Apogee Therapeutics, Inc.
0.89%
Viridian Therapeutics, Inc.
0.88%
Centessa Pharmaceuticals Plc
0.88%
Total10.62%
ETF Description
Virtus LifeSci Biotech Clinical Trials ETF
BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.